Cargando…

Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura

In this study, we investigated a case of pregnancy-onset thrombotic thrombocytopenic purpura (TTP). The patient had severely decreased ADAMTS13 ( a d isintegrin a nd m etalloprotease with t hrombo s pondin type 1 motif, member 13) activity levels during acute phase and the presence of inhibitory ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roose, Elien, Tersteeg, Claudia, Demeersseman, Ruth, Schelpe, An-Sofie, Deforche, Louis, Pareyn, Inge, Vandenbulcke, Aline, Vandeputte, Nele, Dierickx, Daan, Voorberg, Jan, Deckmyn, Hans, De Meyer, Simon F., Vanhoorelbeke, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524854/ https://www.ncbi.nlm.nih.gov/pubmed/31249923 http://dx.doi.org/10.1055/s-0037-1615252

Ejemplares similares

Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura
por: Deforche, Louis, et al.
Publicado: (2016)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
por: Kangro, Kadri, et al.
Publicado: (2020)

Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
por: Schelpe, An-Sofie, et al.
Publicado: (2019)

ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology
por: Joly, Bérangère S., et al.
Publicado: (2022)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
por: Sakai, Kazuya, et al.
Publicado: (2022)

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura
por: Graça, Nuno A. G., et al.
Publicado: (2019)

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease
por: Denorme, Frederik, et al.
Publicado: (2017)

Hereditary Thrombotic Thrombocytopenic Purpura in a Chinese Boy With a Novel Compound Heterozygous Mutation of the ADAMTS13 Gene
por: Dai, Yi-ling, et al.
Publicado: (2020)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2018)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2021)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura()
por: Thomas, Mari R., et al.
Publicado: (2015)

Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
por: Laghmouchi, Aicha, et al.
Publicado: (2021)

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021)

Prasugrel and Acquired Thrombotic Thrombocytopenic Purpura Associated with ADAMTS13 Activity Deficiency
por: Lopez, Yanet Parodis, et al.
Publicado: (2016)

Congenital Thrombotic Thrombocytopenic Purpura With a Novel ADAMTS13 Gene Mutation
por: Rashid, Anila, et al.
Publicado: (2020)

Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity
por: Tellier, Edwige, et al.
Publicado: (2022)

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura
por: Manea, Minola, et al.
Publicado: (2006)

Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?
por: Lombardi, Anna Maria, et al.
Publicado: (2019)

Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
por: Palandri, Francesca, et al.
Publicado: (2021)

Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura
por: Edgar, Contessa E., et al.
Publicado: (2015)

Histone-induced thrombotic thrombocytopenic purpura in adamts13(−/−) zebrafish depends on von Willebrand factor
por: Zheng, Liang, et al.
Publicado: (2020)

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
por: Beranger, Nicolas, et al.
Publicado: (2020)

Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation
por: Vermeersch, Elien, et al.
Publicado: (2018)

Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan
por: Matsumoto, Masanori, et al.
Publicado: (2012)

Management of Thrombotic Thrombocytopenic Purpura with Autoantibodies to ADAMTS-13 and Concurrent Preeclampsia in Pregnancy: Multidisciplinary Team Approach
por: Patrick, Tiffany, et al.
Publicado: (2012)

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation and New ADAMTS 13 Mutation in a Tunisian Child
por: Borgi, A., et al.
Publicado: (2013)

Positive Response and Increase in ADAMTS13 with Scheduled Rituximab in a Patient with Relapsing Thrombotic Thrombocytopenic Purpura
por: Amer, Bahaa, et al.
Publicado: (2019)

Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Vendramin, Chiara, et al.
Publicado: (2018)

An ADAMTS13 mutation that causes hereditary thrombotic thrombocytopenic purpura: a case report and literature review
por: Li, Pengzhu, et al.
Publicado: (2021)

De Novo Mutation of the ADAMTS13 Gene with Mesenteric Ischemia in an Infant with Congenital Thrombotic Thrombocytopenic Purpura
por: Alharbi, Ibrahim, et al.
Publicado: (2021)

Economic impact of a rapid, on‐demand ADAMTS‐13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura
por: White, Alicia, et al.
Publicado: (2022)

ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications
por: Dainese, Cristina, et al.
Publicado: (2022)

Novel Heterozygous Mutations of Congenital Thrombotic Thrombocytopenic Purpura: A Rare Case Report
por: Yadav, Raj K., et al.
Publicado: (2019)

von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome
por: Kraisin, Sirima, et al.
Publicado: (2019)

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura
por: Pereira, Leydi C. Velasquez, et al.
Publicado: (2020)

Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity
por: Ercig, Bogac, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_79beptp57isredm8h85ftr295d